MICRONUTRIENTS DIETS MODIFICATION REDUCED ON BLOOD GLUCOSE OF THE TYPE 2 DIABETES MELLITUS (T2DM) IN WEST JAVA']JAVA, INDONESIA (STUDY ON ENRICHEMENT DIET OF ZINC, SELENIUM AND ZINC AND SELENIUM SELENIUM COMBINED)

被引：0
|
作者：
Judiono, J. [1 ]
Titisundari, R. [1 ]
机构：
[1] MOH RI Nutr Fac, Bandung Hlth Polytech, Java, Indonesia
来源：
ANNALS OF NUTRITION AND METABOLISM | 2013年 / 63卷
关键词：
Diet modification; Zinc; blood glucose; antioxidant;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1324 / 1324
页数：1
相关论文
共 39 条
  • [31] REDUCED INSULIN NEED IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)WITH IRON DEFICIENCY ANEMIA THREATED WITH SUCROSOMIAL IRON VS INTRAVENOUS SODIUM FERRIGLUCONATE. MULTICENTRIC PROSPECTIVE STUDY
    Giordano, G.
    Parente, A.
    Gigli, R.
    Magri, M.
    Berardi, G.
    Carabellese, B.
    D'Amico, F.
    Luciano, L.
    Fratangelo, R.
    Niro, G.
    Licianci, A.
    Di Marzio, L.
    Gasperi, M.
    HAEMATOLOGICA, 2016, 101 : 848 - 848
  • [32] Blood glucose (BG) profiles after transferring from basal insulin to twice daily 30/70 premixed insulin (30/70): An observational study in Asian patients (pts) with type 2 diabetes mellitus (T2DM)
    Mattoo, V
    Mahatma, Y
    Kim, WH
    Park, SW
    Park, KS
    Salazar, GG
    Panelo, AA
    Asdie, AH
    Siddappa, H
    Aruyerchelvan, NB
    Lee, ZSK
    DIABETES, 2004, 53 : A550 - A550
  • [33] Baseline and 12-month vascular risk profile in patients with type 2 diabetes Mellitus (T2DM) according to European diabetes policy group (EDPG) glucose and lipid assessment levels. An observational study in Spain
    Reviriego, J
    Rodriguez, A
    Julian, I
    Polavieja, P
    DIABETES, 2005, 54 : A523 - A523
  • [34] Short-Term Treatment with Glucagon Receptor Antagonist LY2409021 Effectively Reduces Fasting Blood Glucose (FBG) and HbA1c in Patients with Type 2 Diabetes Mellitus (T2DM)
    Kelly, Ronan P.
    Garhyan, Parag
    Abu-Raddad, Eyas J.
    Fu, Haoda
    Lim, Chay Ngee
    Prince, Melvin J.
    Pinaire, Jane A.
    Loh, Mei Teng
    Deeg, Mark A.
    DIABETES, 2011, 60 : A84 - A84
  • [35] Analysis of postprandial time trends and influencing factors of blood glucose and insulin in type 2 diabetes mellitus (T2DM) with metabolic dysfunction-associated steatotic liver disease (MASLD): a retrospective study based on propensity score matching (PSM)
    Qi, Ge-yao
    Wang, Fei
    Shi, Yuan-bo
    Feng, Juan
    Xu, Jin
    ACTA DIABETOLOGICA, 2025,
  • [36] Impact Of Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like-Peptide-1 Agonists On Cardiovascular and Renal Outcomes In Patients With Type 2 Diabetes Mellitus (T2DM) and Autoimmune Diseases: A Global Retrospective Study
    Anuforo, Anderson
    Somerville, Alexander
    Bhandari, Jenish
    Sherazi, Mahnoor
    Gautam, Kamal
    Olojakpoke, Eloho
    Awoyemi, Toluwalase
    Makri, Helena
    Poudyal, Bhavya
    Kadel, Anuj
    Sandhu, Prabhjeet
    Draytsel, Dan
    Melfi, Michelle
    Perl, Andras
    Taub, Cynthia
    CIRCULATION, 2024, 150
  • [37] Effect of metformin vs. repaglinide on glycaemic control and non-glycaemic cardiovascular risk-factors in non-obese patients with Type 2 diabetes mellitus (T2DM) uncontrolled by diet (The ReMet-study)
    Lund, SS
    Tarnow, L
    Poulsen, G
    Frandsen, M
    Smith, UM
    Pedersen, O
    Parving, HH
    Vaag, A
    DIABETOLOGIA, 2004, 47 : A252 - A252
  • [38] Ultra-rapid BioChaperone Lispro (BCLIS) Improves Postprandial Blood Glucose (PPG) Control vs. Insulin Lispro (LIS) in a 14-Day Treatment Study in Subjects with Type 2 Diabetes (T2DM)
    Heise, Tim
    Meiffren, Gregory
    Lamers, Daniela
    Kronshage, Birgit
    Ranson, Aymeric
    Alluis, Bertrand
    Gaudier, Martin
    Anastassiadis, Ernestos
    Kazda, Christof
    Hardy, Thomas A.
    Soula, Olivier
    Bruce, Simon
    DIABETES, 2017, 66 : A259 - A259
  • [39] Effect of metformin vs. repaglinide on glycemic control and non-glycerine cardiovascular risk-factors in non-obese patients with type-2 diabetes mellitus (T2DM) uncontrolled by diet (The ReMet-Study)
    Lund, S
    Tarnow, L
    Frandsen, M
    Pedersen, O
    Parving, HH
    Vaag, A
    DIABETES, 2003, 52 : A451 - A451
1234